FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Elisa Bal de Kier Joffé

Research Profile

Living Beings

Disorders

Anatomy

Chemicals & Drugs

Physiology

Phenomena

Blotting, Western

Co-author Network

Publications

TOP 3
M Cecilia Daroqui; Andrei V Bakin; Elisa Bal de Kier Joffé; Paula Vazquez; Lydia Puricelli
TGF-β autocrine pathway and MAPK signaling promote cell invasiveness and in vivo mammary adenocarcinoma tumor progression.
Soledad Bustillo; María E García Denegri; Claudia C Gay; Ofelia Acosta; Elisa Bal de Kier Joffé; Luis Alberto Ponce-Soto; Laura C Leiva
Synergism between baltergin metalloproteinase and Ba SPII RP4 PLA2 from Bothrops alternatus venom on skeletal muscle (C2C12) cells.
María Ines Díaz Bessone; Damian E Berardi; Paola B Campodónico; Laura Todaro; Leonard Lothstein; Elisa Bal de Kier Joffé; Alejandro J Urtreger
Involvement of PKC delta (PKCδ) in the resistance against different doxorubicin analogs.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Elisa Bal de Kier Joffé (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: M Cecilia Daroqui; Andrei V Bakin; Elisa Bal de Kier Joffé; Paula Vazquez; Lydia Puricelli
TGF-β autocrine pathway and MAPK signaling promote cell invasiveness and in vivo mammary adenocarcinoma tumor progression.
Oncology reports 2012;28(2):567-75.
2012: Soledad Bustillo; María E García Denegri; Claudia C Gay; Ofelia Acosta; Elisa Bal de Kier Joffé; Luis Alberto Ponce-Soto; Laura C Leiva
Synergism between baltergin metalloproteinase and Ba SPII RP4 PLA2 from Bothrops alternatus venom on skeletal muscle (C2C12) cells.
Toxicon : official journal of the International Society on Toxinology 2012;59(2):338-43.
2011: María Ines Díaz Bessone; Damian E Berardi; Paola B Campodónico; Laura Todaro; Leonard Lothstein; Elisa Bal de Kier Joffé; Alejandro J Urtreger
Involvement of PKC delta (PKCδ) in the resistance against different doxorubicin analogs.
Breast cancer research and treatment 2011;126(3):577-87.
2010: Laura Valeria Mauro; Mercedes Dalurzo; María José Carlini; David Smith; Myriam Nuñez; Marina Simian; José Lastiri; Bartolomé Vasallo; Elisa Bal de Kier Joffé; María Guadalupe Pallotta; Lydia Puricelli
Estrogen receptor β and epidermal growth factor receptor as early-stage prognostic biomarkers of non-small cell lung cancer.
Oncology reports 2010;24(5):1331-8.
2010: C Buchanan; I Stigliano; H M Garay-Malpartida; L Rodrigues Gomes; Lydia Puricelli; Mari C Sogayar; Elisa Bal de Kier Joffé; M G Peters
Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways.
Breast cancer research and treatment 2010;119(3):559-74.
2010: Laura V Mauro; Valeria C Grossoni; Alejandro J Urtreger; Chengfeng Yang; Lucas L Colombo; Ana Morandi; María G Pallotta; Marcelo G Kazanietz; Elisa Bal de Kier Joffé; Lydia L Puricelli
PKC Delta (PKCdelta) promotes tumoral progression of human ductal pancreatic cancer.
Pancreas 2010;39(1):e31-41.
2009: Ivan Stigliano; Lydia Puricelli; Jorge Filmus; Mari Cleide Sogayar; Elisa Bal de Kier Joffé; María Giselle Peters
Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation.
Breast cancer research and treatment 2009;114(2):251-62.
2008: Soledad Galli; Valeria Gabriela Antico Arciuch; Cecilia Poderoso; Daniela P Converso; Qiongqiong Zhou; Elisa Bal de Kier Joffé; Enrique Cadenas; Jorge Boczkowski; Maria Cecilia Carreras; Juan J Poderoso
Tumor cell phenotype is sustained by selective MAPK oxidation in mitochondria.
PloS one 2008;3(6):e2379.
2007: Romina Carnevale; Cecilia J Proietti; Mariana Salatino; Alejandro J Urtreger; Guillermo Peluffo; Dean P Edwards; Viroj Boonyaratanakornkit; Eduardo H Charreau; Elisa Bal de Kier Joffé; Roxana Schillaci; Patricia V Elizalde
Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
Molecular endocrinology (Baltimore, Md.) 2007;21(6):1335-58.
2007: Laura Todaro; Silvia Christiansen; Mirta Varela; Paola Campodónico; María Guadalupe Pallotta; José Lastiri; Eugenia Sacerdote De Lustig; Elisa Bal de Kier Joffé; Lydia Puricelli
Alteration of serum and tumoral neural cell adhesion molecule (NCAM) isoforms in patients with brain tumors.
Journal of neuro-oncology 2007;83(2):135-44.
2007: Cecilia M Daroqui; Juan M Ilarregui; Natalia Rubinstein; Mariana Salatino; Marta Toscano; Paula Vazquez; Andrei Bakin; Lydia Puricelli; Elisa Bal de Kier Joffé; Gabriel A Rabinovich
Regulation of galectin-1 expression by transforming growth factor beta1 in metastatic mammary adenocarcinoma cells: implications for tumor-immune escape.
Cancer immunology, immunotherapy : CII 2007;56(4):491-9.
2007: Valeria C Grossoni; Karina B Falbo; Laura V Mauro; Martin Krasnapolski; Marcelo G Kazanietz; Elisa Bal de Kier Joffé; Alejandro J Urtreger
Protein kinase C delta inhibits the production of proteolytic enzymes in murine mammary cells.
Clinical & experimental metastasis 2007;24(7):513-20.
2006: Alejandro J Urtreger; Santiago E Werbajh; Franck Verrecchia; Alain Mauviel; Lydia Puricelli; Alberto R Kornblihtt; Elisa Bal de Kier Joffé
Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential.
Oncology reports 2006;16(6):1403-10.
2005: Alejandro J Urtreger; Valeria C Grossoni; Karina B Falbo; Marcelo G Kazanietz; Elisa Bal de Kier Joffé
Atypical protein kinase C-zeta modulates clonogenicity, motility, and secretion of proteolytic enzymes in murine mammary cells.
Molecular carcinogenesis 2005;42(1):29-39.
2004: Maria Giselle Peters; Maria del Carmen C Vidal; Liliana Giménez; Laura Mauro; Eduardo Armanasco; Carlos Cresta; Elisa Bal de Kier Joffé; Lydia Puricelli
Prognostic value of cell cycle regulator molecules in surgically resected stage I and II breast cancer.
Oncology reports 2004;12(5):1143-50.
2004: Stella Maris Ranuncolo; Mirta Varela; Ana Morandi; José Lastiri; Silvia Christiansen; Elisa Bal de Kier Joffé; María Guadalupe Pallotta; Lydia Puricelli
Prognostic value of Mdm2, p53 and p16 in patients with astrocytomas.
Journal of neuro-oncology 2004;68(2):113-21.
2004: Laura Todaro; Lydia Puricelli; Hernán Gioseffi; María Guadalupe Pallotta; José Lastiri; Elisa Bal de Kier Joffé; Mirta Varela; Eugenia Sacerdote De Lustig
Neural cell adhesion molecule in human serum. Increased levels in dementia of the Alzheimer type.
Neurobiology of disease 2004;15(2):387-93.
2003: Soledad Galli; Mariana Inés Labato; Elisa Bal de Kier Joffé; Maria Cecilia Carreras; Juan J Poderoso
Decreased mitochondrial nitric oxide synthase activity and hydrogen peroxide relate persistent tumoral proliferation to embryonic behavior.
Cancer research 2003;63(19):6370-7.
2003: M Cecilia Daroqui; Lydia Puricelli; Alejandro J Urtreger; Patricia V Elizalde; Guillermo M Lanuza; Elisa Bal de Kier Joffé
Involvement of TGF-beta(s)/T(beta)Rs system in tumor progression of murine mammary adenocarcinomas.
Breast cancer research and treatment 2003;80(3):287-301.
2003: M G Peters; Eduardo F Farías; L Colombo; J Filmus; Lydia Puricelli; Elisa Bal de Kier Joffé
Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model.
Breast cancer research and treatment 2003;80(2):221-32.
2003: Laura Todaro; Virginia Ladeda; Elisa Bal de Kier Joffé; Eduardo F Farías
Combined treatment with verapamil, a calcium channel blocker, and B428, a synthetic uPA inhibitor, impairs the metastatic ability of a murine mammary carcinoma.
Oncology reports 2003;10(3):725-32.
2002: Lydia Puricelli; Cecilia J Proietti; Cecilia J Proiettii; Leticia Labriola; Mariana Salatino; Maria Balañá; Julio A Aguirre Ghiso; Ruth Lupu; Omar P Pignataro; Eduardo H Charreau; Elisa Bal de Kier Joffé; Patricia V Elizalde
Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells.
International journal of cancer. Journal international du cancer 2002;100(6):642-53.
2002: Stella Maris Ranuncolo; Elena Matos; Dora Loria; Marta Vilensky; Rodrigo Rojo; Elisa Bal de Kier Joffé; Lydia Inés Puricelli
Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma.
Cancer 2002;94(5):1483-91.
2002: Stella Maris Ranuncolo; Virginia Ladeda; Sergio Specterman; Mirta Varela; José Lastiri; Ana Morandi; Elena Matos; Elisa Bal de Kier Joffé; Lydia Puricelli; María Guadalupe Pallotta
CD44 expression in human gliomas.
Journal of surgical oncology 2002;79(1):30-5; discussion 35-6.
2001: Virginia Ladeda; A P Adam; Lydia Puricelli; Elisa Bal de Kier Joffé
Apoptotic cell death in mammary adenocarcinoma cells is prevented by soluble factors present in the target organ of metastasis.
Breast cancer research and treatment 2001;69(1):39-51.
2000: Ana María Eiján; Eduardo Sandes; Lydia Puricelli; Elisa Bal de Kier Joffé; Alberto R Casabé
Cathepsin B levels in urine from bladder cancer patients.
Oncology reports 2000;7(6):1395-9.
1999: DANIEL ALONSO; Guillermo Skilton; Eduardo F Farías; Elisa Bal de Kier Joffé; daniel gomez
Antimetastatic effect of desmopressin in a mouse mammary tumor model.
Breast cancer research and treatment 1999;57(3):271-5.
1998: Eduardo F Farías; Julio A Aguirre Ghiso; Virginia Ladeda; Elisa Bal de Kier Joffé
Verapamil inhibits tumor protease production, local invasion and metastasis development in murine carcinoma cells.
International journal of cancer. Journal international du cancer 1998;78(6):727-34.
1998: Santiago E Werbajh; Alejandro J Urtreger; Lydia Puricelli; Eugenia Sacerdote De Lustig; Elisa Bal de Kier Joffé; Alberto R Kornblihtt
Downregulation of fibronectin transcription in highly metastatic adenocarcinoma cells.
FEBS letters 1998;440(3):277-81.
1998: Alejandro J Urtreger; Fabiola Porro; Lydia Puricelli; Santiago E Werbajh; Francisco E Baralle; Elisa Bal de Kier Joffé; Alberto R Kornblihtt; Andrés F Muro
Expression of RGD minus fibronectin that does not form extracellular matrix fibrils is sufficient to decrease tumor metastasis.
International journal of cancer. Journal international du cancer 1998;78(2):233-41.
1998: Virginia Ladeda; Julio A Aguirre Ghiso; Elisa Bal de Kier Joffé
Function and expression of CD44 during spreading, migration, and invasion of murine carcinoma cells.
Experimental cell research 1998;242(2):515-27.
1998: Julio A Aguirre Ghiso; Eduardo F Farías; DANIEL ALONSO; Elisa Bal de Kier Joffé
Secretion of urokinase and metalloproteinase-9 induced by staurosporine is dependent on a tyrosine kinase pathway in mammary tumor cells.
International journal of cancer. Journal international du cancer 1998;76(3):362-7.
1997: Gabriel Bertolesi; Eduardo F Farías; DANIEL ALONSO; Elisa Bal de Kier Joffé; S Lauría de Cidre; Ana María Eiján
Insight into the profibrinolytic activity of heparin: effects on the activation of plasminogen mediated by urokinase.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1997;8(7):403-10.
1997: Julio A Aguirre Ghiso; Eduardo F Farías; DANIEL ALONSO; C Arregui; Elisa Bal de Kier Joffé
A phospholipase D and protein kinase C inhibitor blocks the spreading of murine mammary adenocarcinoma cells altering f-actin and beta1-integrin point contact distribution.
International journal of cancer. Journal international du cancer 1997;71(5):881-90.
1997: Julio A Aguirre Ghiso; DANIEL ALONSO; Eduardo F Farías; Elisa Bal de Kier Joffé
Overproduction of urokinase-type plasminogen activator is regulated by phospholipase D- and protein kinase C-dependent pathways in murine mammary adenocarcinoma cells.
Biochimica et biophysica acta 1997;1356(2):171-84.
1997: Julio A Aguirre Ghiso; Miriam J Diament; I D'elia; Elisa Bal de Kier Joffé; S Klein
Effects of in vivo culture of murine mammary adenocarcinoma cells on tumor and metastatic growth.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1997;18(1):41-52.
1996: DANIEL ALONSO; Eduardo F Farías; Alejandro J Urtreger; Virginia Ladeda; M C Vidal; Elisa Bal de Kier Joffé
Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma.
Journal of surgical oncology 1996;62(4):288-97.
1996: F K Guerra; A M Eijan; Lydia Puricelli; DANIEL ALONSO; Elisa Bal de Kier Joffé; A R Kornblihgtt; Eduardo H Charreau; Patricia V Elizalde
Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability.
International journal of cancer. Journal international du cancer 1996;65(6):812-20.
1996: DANIEL ALONSO; Eduardo F Farías; Virginia Ladeda; Lilia Davel; Lydia Puricelli; Elisa Bal de Kier Joffé
Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor model.
Breast cancer research and treatment 1996;40(3):209-23.
1994: Ana María Eiján; Lydia Puricelli; Elisa Bal de Kier Joffé; C Elías; S R Leicach; R A Cadenas
Action of nitrogenated and sulfonylated inositol derivatives upon the proliferation in vitro of normal mouse cells and tumor mouse cells.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1994;15(6):354-60.
1994: Lydia Puricelli; D E Gómez; M C Vidal; Ana María Eiján; O Spinelli; DANIEL ALONSO; Eugenia Sacerdote De Lustig; Elisa Bal de Kier Joffé
Effect of host-organ environment on the in vivo and in vitro behavior of a murine mammary adenocarcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1994;15(5):284-93.
1993: DANIEL ALONSO; Eduardo F Farías; Elisa Bal de Kier Joffé
Impairment of fibrinolysis during the growth of two murine mammary adenocarcinomas.
Cancer letters 1993;70(3):181-7.
1992: S Pereyra-Alfonso; G R Solarz; Elisa Bal de Kier Joffé
Urokinase-type plasminogen activator activity increases during the growth of two murine mammary adenocarcinomas with different metastasizing abilities.
Clinical & experimental metastasis 1992;10(6):395-401.
1992: DANIEL ALONSO; Elisa Bal de Kier Joffé
[Role of plasminogen activators in cancer dissemination. Clinical perspectives].
Medicina 1992;52(3):252-6.
1991: Elisa Bal de Kier Joffé; DANIEL ALONSO; Lydia Puricelli
Soluble factors released by the target organ enhance the urokinase-type plasminogen activator activity of metastatic tumor cells.
Clinical & experimental metastasis 1991;9(1):51-6.
1991: Andrés F Muro; Lydia Puricelli; Alberto R Kornblihtt; Elisa Bal de Kier Joffé
Inverse correlation between fibronectin mRNA levels and the metastatic potential of two murine mammary adenocarcinomas.
Invasion & metastasis 1991;11(5):281-7.
1990: L L Colombo; daniel gomez; Lydia Puricelli; M C Vidal; R Ponzio; Elisa Bal de Kier Joffé
In vivo selection and characterization of a murine mammary tumor subline with high potential for spontaneous lymph node metastasis.
Journal of surgical oncology 1990;45(3):190-5.
1990: Lydia Puricelli; L L Colombo; D E Gómez; M C Vidal; Elisa Bal de Kier Joffé
Characterization of a new murine tumor variant with different in vivo behavior selected by its adhesive properties.
Tumori 1990;76(4):345-9.
1988: S Pereyra-Alfonso; A Haedo; Elisa Bal de Kier Joffé
Correlation between urokinase-type plasminogen activator production and the metastasizing ability of two murine mammary adenocarcinomas.
International journal of cancer. Journal international du cancer 1988;42(1):59-63.
1988: Elisa Bal de Kier Joffé; Lydia Puricelli; R Mariotto; A M Eijan; Eugenia Sacerdote De Lustig
Fibronectin and laminin expression in breast cancer and lymph node metastases. Lack of correlation with fibronectin plasmatic levels.
Medicina 1988;48(5):499-505.
1987: Lydia Puricelli; D E Gómez; Elisa Bal de Kier Joffé
[Analysis of the metastatic process].
Medicina 1987;47(3):313-6.
1986: Ana María Eiján; Lydia Puricelli; Elisa Bal de Kier Joffé; D Entin; D Vuoto; E Orlando; Eugenia Sacerdote De Lustig
Serial analysis of fibronectin concentration in plasma of patients with benign and malignant breast diseases.
Cancer 1986;57(7):1345-9.
1986: Elisa Bal de Kier Joffé; Lydia Puricelli; Eugenia Sacerdote De Lustig
Modified adhesion behavior after in vitro passage of two related murine mammary adenocarcinomas with different metastasizing ability.
Invasion & metastasis 1986;6(5):302-12.
1985: Lydia Puricelli; Elisa Bal de Kier Joffé; Ana María Eiján; D Entín; Eugenia Sacerdote De Lustig
Levels of plasmatic fibronectin in mice bearing adenocarcinomas of different metastasizing ability.
Cancer letters 1985;29(2):189-95.
1984: Lydia Puricelli; L L Colombo; Elisa Bal de Kier Joffé; Eugenia Sacerdote De Lustig
Invasiveness in vitro of two mammary adenocarcinoma tumors with different metastasizing ability.
Invasion & metastasis 1984;4(4):238-46.
1981: Lydia Puricelli; Elisa Bal de Kier Joffé; Lilia Davel; Eugenia Sacerdote De Lustig
Isolation and partial characterization of a morphogenetic factor from human leucocyte interferon.
Cellular and molecular biology, including cyto-enzymology 1981;27(6):607-14.